Hope Takes Action - HIV Vaccine Trial in Chicago!

Every 10 minutes, someone in the United States is infected with HIV. A preventive vaccine against HIV offers the best long-term hope to end this worldwide epidemic. Finding a safe and effective HIV vaccine that will protect people is a huge task. We cannot do it without your help.

  • We are currently seeking 1350 men who have sex with men to participate in a vaccine trial. You cannot become infected with HIV from the vaccines.
  • The study will take place in several cities in the United States.

Participants must be:

  • Men who have sex with men
  • 18-45 years old
  • HIV-negative
  • Circumcised

Safety is a primary goal of the vaccine trial. This is a Phase II study, designed to yield limited information on the effectiveness of the vaccine. The research vaccines have been found to be safe in animals and hundreds of humans in previous trials. One of the vaccines is made from an inactivated cold virus known as an adenovirus. The vaccines do NOT contain the HIV virus, and CANNOT cause HIV infection. Since these vaccines are still being researched, we urge all of our participants to practice safe sex.

The HIV vaccine trial is a collaboration between the HIV Vaccine Trials Network, the Division of AIDS, NIAID and the Vaccine Research Center, NIAID.

For  Chicago  -  contact   Project WISH / University of Illinois at Chicago
840 S. Wood St, Room B39      Chicago, IL 60612          312 413-5897


The  Best   of  Gay  Chicago

 

What did you think of this article?




Trackbacks
  • No trackbacks exist for this post.
Comments

  • 3/10/2010 3:18 AM HPV Treatment wrote:
    I can't believe we don't have a vaccine yet! The only thing about the trial is, with the current paranoia in the public re vaccines, those who contract the virus will BLAME the vaccine, rather than blame the efficacy of the vaccine. Just watch - law suits everywhere, wasting tax payer money and research time.I hope the sponsors know what they are in for.
    Reply to this
Leave a comment

Submitted comments are subject to moderation before being displayed.

 Enter the above security code (required)

 Name

 Email (will not be published)

 Website

Your comment is 0 characters limited to 3000 characters.